List of bibliographic references indexed by Dyskinesia, Drug-Induced (etiology)
Number of relevant bibliographic references: 45.
[0-20] [
0 - 20][
0 - 45][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000373 (2016) |
N. Simon [France] ; F. Viallet [France] ; A. Boulamery [France] ; A. Eusebio [France] ; D. Gayraud [France] ; J-P Azulay [France] | A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson's disease patients. |
| 000489 (2015) |
Marianne Amalric [France] | Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease. |
| 000562 (2015) |
Olivier Rascol [France] ; Santiago Perez-Lloret ; Joaquim J. Ferreira [Portugal] | New treatments for levodopa-induced motor complications. |
| 000566 (2015) |
Margarita Garcia-Amador [Espagne] ; Jessica Merchán-Naranjo ; Cecilia Tapia ; Carmen Moreno ; Josefina Castro-Fornieles ; Inmaculada Baeza ; Elena De La Serna ; José A. Alda ; Daniel Mu Oz ; Patricia Andrés Nestares ; Carmen Martínez Cantarero ; Celso Arango | Neurological Adverse Effects of Antipsychotics in Children and Adolescents. |
| 000573 (2015) |
H. Iderberg [Suède] ; A C Mccreary [Pays-Bas] ; M A Varney [États-Unis] ; M S Kleven [France] ; W. Koek [France] ; L. Bardin [France] ; R. Depoortère [France] ; M A Cenci [Suède] ; A. Newman-Tancredi [États-Unis] | NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat. |
| 000651 (2015) |
C. Fidalgo [Italie] ; W K D. Ko [Royaume-Uni] ; E. Tronci [Italie] ; Q. Li [République populaire de Chine] ; R. Stancampiano [Italie] ; Q. Chuan [République populaire de Chine] ; E. Bezard [République populaire de Chine] ; M. Carta [Italie] | Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease. |
| 000920 (2014) |
Cristina Alcacer [France] ; Fanny Charbonnier-Beaupel [France] ; Jean-Christophe Corvol [France] ; Jean-Antoine Girault [France] ; Denis Hervé [France] | Mitogen- and stress-activated protein kinase 1 is required for specific signaling responses in dopamine-denervated mouse striatum, but is not necessary for L-DOPA-induced dyskinesia. |
| 000993 (2014) |
Wai Kin D. Ko [France] ; Qin Li [République populaire de Chine] ; Erwan Bezard [République populaire de Chine] | Effects of L-tryptophan on L-DOPA-induced dyskinesia in the L-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson's disease. |
| 000A28 (2014) |
Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. Facheris | Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. |
| 000C44 (2013) |
M. Verdet [France] ; J. Nicolau ; R. Lefaucheur ; D. Maltête ; S. Derrey ; A. Daragon | Recurrent bilateral metatarsal "stress-and-insufficiency" fractures in a levodopa-treated young woman with Parkinson's disease. |
| 000E27 (2013) |
Erwan Bezard [France, République populaire de Chine] ; Elisabetta Tronci [Italie, Suède] ; Elsa Y. Pioli [Royaume-Uni] ; Qin Li [République populaire de Chine, Royaume-Uni] ; Gregory Porras [Royaume-Uni] ; Anders Björklund [Suède] ; Manolo Carta [Italie, Suède] | Study of the antidyskinetic effect of eltoprazine in animal models of levodopa‐induced dyskinesia |
| 001062 (2012) |
Eugénie Lhommée [France] ; Hélène Klinger ; Stéphane Thobois ; Emmanuelle Schmitt ; Claire Ardouin ; Amélie Bichon ; Andrea Kistner ; Valérie Fraix ; Jing Xie ; Magaly Aya Kombo ; Stephan Chabardès ; Eric Seigneuret ; Alim-Louis Benabid ; Patrick Mertens ; Gustavo Polo ; Sebastien Carnicella ; Jean-Louis Quesada ; Jean-Luc Bosson ; Emmanuel Broussolle ; Pierre Pollak ; Paul Krack | Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. |
| 001089 (2012) |
O. Rascol [France] ; J. Bronzova ; R A Hauser ; A E Lang ; C. Sampaio ; A. Theeuwes ; S V Van De Witte | Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial. |
| 001F23 (2009) |
Céline Guigoni [France] ; Erwan Bezard | Involvement of canonical and non-canonical D1 dopamine receptor signalling pathways in L-dopa-induced dyskinesia. |
| 001F30 (2009) |
Christelle Monville [France] ; Eduardo M. Torres ; Vladimir Pekarik ; Emma L. Lane ; Stephen B. Dunnett | Genetic, temporal and diurnal influences on L-dopa-induced dyskinesia in the 6-OHDA model. |
| 001F39 (2009) |
Amandine Berthet [France] ; Erwan Bezard | Dopamine receptors and L-dopa-induced dyskinesia. |
| 002295 (2008) |
Agnès Nadjar [France] ; Charles R. Gerfen [États-Unis] ; Erwan Bezard [France] | Priming for L-dopa-induced dyskinesia in Parkinson’s disease: a feature inherent to the treatment or the disease? |
| 002A02 (2006) |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
| 002B71 (2005) |
C. Guigoni [France] ; I. Aubert ; Q. Li ; V V Gurevich ; J L Benovic ; S. Ferry ; U. Mach ; H. Stark ; L. Leriche ; K. H Kansson ; Bernard H. Bioulac ; Christian E. Gross ; Pierre Sokoloff ; Gilberto Fisone ; E V Gurevich ; Bertrand Bloch ; Erwan Bezard | Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. |
| 002D84 (2005) |
Véronique Sgambato-Faure [France] ; Virginie Buggia [France] ; Frangois Gilbert [Canada] ; Daniel Levesque [Canada] ; Alim-Louis Benabid [France] ; Francois Berger [France] | Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-lnduced behavioral sensitization in dyskinetic rats |
| 002E49 (2004) |
F. Durif [France] ; B. Debilly ; M. Galitzky ; D. Morand ; F. Viallet ; M. Borg ; S. Thobois ; E. Broussolle ; O. Rascol | Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dyskinesia, Drug-Induced (etiology)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i \
-Sk "Dyskinesia, Drug-Induced (etiology)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdEn.i
|clé= Dyskinesia, Drug-Induced (etiology)
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
